Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

[1]  R. Busse,et al.  Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells , 2005, Journal of cellular physiology.

[2]  M. Gonthier,et al.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes , 2005, Histochemistry and Cell Biology.

[3]  O. Prospero-Garcia,et al.  Oleamide and anandamide effects on food intake and sexual behavior of rats , 2004, Neuroscience Letters.

[4]  B. Cravatt,et al.  The endogenous cannabinoid system protects against colonic inflammation. , 2004, The Journal of clinical investigation.

[5]  Thomas W. Klein,et al.  Cannabinoid receptors and T helper cells , 2004, Journal of Neuroimmunology.

[6]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[7]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[8]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[9]  M. Breschi,et al.  CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  C. Flachskamm,et al.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. , 2003, The Journal of clinical investigation.

[11]  P. Soubrié,et al.  The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. , 2003, Molecular pharmacology.

[12]  D. Cota,et al.  Endogenous cannabinoid system as a modulator of food intake , 2003, International Journal of Obesity.

[13]  D. Piomelli,et al.  A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding , 2002, The Journal of Neuroscience.

[14]  E. Berry,et al.  Tetrahydrocannabinol and endocannabinoids in feeding and appetite. , 2002, Pharmacology & therapeutics.

[15]  D. Piomelli,et al.  The endocannabinoid system as a target for therapeutic drugs. , 2000, Trends in pharmacological sciences.

[16]  A. Makriyannis,et al.  Functional CB1 cannabinoid receptors in human vascular endothelial cells. , 2000, The Biochemical journal.

[17]  G. Cabral,et al.  Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. , 1999, The Journal of pharmacology and experimental therapeutics.

[18]  Z. Vogel,et al.  Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase Isozymes , 1998, Journal of neurochemistry.

[19]  L. Petrocellis,et al.  An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. , 1998, European journal of pharmacology.

[20]  P. Casellas,et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[21]  M. Glass,et al.  Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a Gs Linkage to the CB1 Receptor , 1997, The Journal of Neuroscience.

[22]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[23]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[24]  A. Buriani,et al.  Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[26]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[27]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[28]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Mechoulam,et al.  Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase , 1993, Journal of neurochemistry.

[30]  P. Casellas,et al.  Cannabinoid-receptor expression in human leukocytes. , 1993, European journal of biochemistry.

[31]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[32]  L. Matsuda,et al.  Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. , 1992, Molecular pharmacology.

[33]  M. Herkenham,et al.  The cannabinoid receptor: biochemical, anatomical and behavioral characterization , 1990, Trends in Neurosciences.

[34]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[35]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[37]  W. Sandritter,et al.  Eine Methode zur histochemischen Bestimmung von RNS und DNS an der gleichen Zelle , 1969, Histochemie.

[38]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[39]  M. Glass,et al.  Cannabinoid receptors and their endogenous agonists. , 1998, Annual review of pharmacology and toxicology.

[40]  G. Cabral,et al.  Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. , 1994, Life sciences.